Despite that IQGAP3 was found as the most conspicuously overexpressed gene in DLBCL samples relative to normal controls, patients with high IQGAP3 expression had a much better clinical outcome, as indicated by longer progression-free (PFS) and overall survival (OS) [75]. Here, IQGAP3 is linked to diffuse large B-cell lymphoma.